VX-264

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VX-264, covering 2025-08-11 to 2025-08-11. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes [Phase 1, Phase 2]